EN
HI
Summary
As of 19 Sep, 2026, Gland Pharma stock price is ₹2961.9. During the trading session, the stock has moved between an intraday low of ₹2904.00 and an intraday high of ₹2978.00. Over the last 52 weeks, Gland Pharma has traded between ₹1573.60 and ₹3042.00.
The stock has recorded a trading volume of 4,92,452 shares,. Its Average Traded Price (ATP) is ₹2957.22, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹2961.90.
Gland Pharma has an upper circuit limit of ₹3554.20 and a lower circuit limit of ₹2369.60. The total value traded stands at ₹145.63 CR, and the delivery percentage for the day is 61.88%.
The stock is currently traded with a market lot size of 1. Gland Pharma also offers a dividend yield of 0.68%.
Gland Pharma Share Price Chart
Gland Pharma Share Key Metrics
Volume
4.92 L
Market Cap
48859.41 CR
LTQ@LTP
1@2961.90
ATP
2957.22
Var Margin
17.11 %
Circuit Range
2369.6-3554.2
Delivery %
61.88 %
Value
145.63 CR
ASM/GSM
No
Market Lot
1
Gland Pharma Fundamentals
P/E Ratio
43.3
P/B Ratio
4.6
Div. Yield
0.68
Sector P/E
42.35
Sector P/B
3.6
Sec. Div. Yield
0.51
Gland Pharma Resistance and Support
Pivot 2889.67
Resistance
First Resistance
2959.24
Second Resistance
3010.67
Third Resistance
3080.24
Support
First Support
2838.24
Second Support
2768.67
Third Support
2717.24
Gland Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 18 2026 | 2907.2 | 2961.9 | 1.86% | 2978 | 2904 |
| Thu Sep 17 2026 | 2827.89 | 2907.8 | 2.87% | 2941.1 | 2820.1 |
| Wed Sep 16 2026 | 2877 | 2826.6 | -2.38% | 2914.19 | 2792.39 |
Gland Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-01-28 | Quarterly Results |
| 2025-11-03 | Quarterly Results |
| 2025-08-05 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results |
| 2024-11-04 | Quarterly Results |
| 2024-08-06 | Quarterly Results |
Gland Pharma News
Gland Pharma Ltd - 543245 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Gland Pharma's promoter group, Fosun Pharma Industrial Pte. Ltd., sold 98.97 lakh equity shares, representing a 6.00% stake reduction. The transaction occurred via open market on September 4, 2026, lowering their total holding to 45.76%.
Sep 08 2026 12:46:12
Gland Pharma Ltd - 543245 - Conclusion Of USFDA Inspection At Company''s Facilities Situated At Visakhapatnam
Gland Pharma's VSEZ Sterile Oncology Formulations Facility and API Facility in Visakhapatnam completed a routine USFDA GMP inspection. The inspection concluded with zero Form 483 observations, indicating full compliance.
Sep 01 2026 15:49:38
Read More
Gland Pharma Management
| Name | Position |
|---|---|
| Sampath Kumar Pallerlamudi | Company Secretary & Compliance Officer |
| Srinivas Sadu | Chairman |
Gland Pharma Similar Stocks
Biocon Ltd.
385.00
5.00 (1.32%)
Abbott India Ltd.
27270.00
1360.00 (5.25%)
Anthem Biosciences Ltd.
928.50
1.10 (0.12%)
Ipca Laboratories Ltd.
2009.60
39.30 (1.99%)
Glaxosmithkline Pharmaceuticals Ltd.
2838.80
38.90 (1.39%)
Ajanta Pharma Ltd.
3563.60
63.10 (1.80%)
Narayana Hrudayalaya Ltd.
1928.50
59.90 (3.21%)
Global Health Ltd.
1499.40
75.40 (5.29%)
Emcure Pharmaceuticals Ltd.
2003.80
94.00 (4.92%)
Gland Pharma FAQs
The Buying Price of Gland Pharma share is 2961.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Gland Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gland Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Gland Pharma shares is 43.3. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Gland Pharma shares is 4.6. Useful to assess the stock's value relative to its book value.
To assess Gland Pharma’s valuation compare Sector P/E, P/B which are 42.35 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Gland Pharma is 48859.41 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Gland Pharma share price is 3042.00 & 1573.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Gland Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in GLAND
